Clinical Trials Logo
  1. Home
  2. Other
  3. NCT06317441

The Safety and Efficacy of a Probiotic Intervention on SIBO and Related Gastrointestinal Symptoms

Small Intestinal Bacterial Overgrowth Clinical Trial

Official title:
The Safety and Efficacy of a Probiotic Intervention on SIBO and Related Gastrointestinal Symptoms

Clinical Trial Summary

In this study, the goal is to evaluate whether a probiotic formula may reduce symptoms of bloating and abdominal distension in a population suffering from Small Intestinal Bacterial Overgrowth (SIBO) in comparison to a placebo. In addition to the incidence of SIBO, changes to other gastrointestinal symptoms will be assessed. Lastly, the associations between the SIBO status and microbiome from the small and large intestines will be explored using the SIMBA capsule.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

  • Small Intestinal Bacterial Overgrowth
Clinical Trial Details
NCT number NCT06317441
Study type Interventional
Source Nimble Science Ltd.
Contact Gwen Duytschaever, PhD
Phone 4037032436
Email gwen@nimblesci.com
Status Not yet recruiting
Phase N/A
Start date May 2024
Completion date December 2024
View Details
See also
  Status Clinical Trial Phase
Completed NCT03318614 - Bifidobacterium Infantis M-63 Improves Mental Health in Irritable Bowel Syndrome Developed After a Major Flood Disaster Phase 2/Phase 3
Completed NCT02251483 - Use of SBI in IBS Subjects Following a Successful Treatment of Small Intestinal Bacterial Overgrowth N/A
Withdrawn NCT04244877 - Rifaximin's Effect on Covert Hepatic Encephalopathy With SIBO and Gastrointestinal Dysmotility Phase 3
Completed NCT06162702 - Clinical Study of Fecal Microbiota Transplantation in the Treatment of Small Intestinal Bacterial Overgrowth (SIBO) N/A
Completed NCT00680836 - Gulf War Digestive Health Study N/A
Enrolling by invitation NCT03659175 - Characteristic of Intestinal Flora in Male Elderly With Small Intestinal Bacterial Overgrowth
Recruiting NCT04506593 - Indiana University Gastrointestinal Motility Diagnosis Registry
Terminated NCT04316806 - Effect of a Probiotic Formula on Reducing SIBO in IBS Patients N/A
Completed NCT05765994 - Small Intestinal Bacterial Overgrowth in Critically Ill Patients
Recruiting NCT05967871 - Pilot Feasibility Study of Fecal Microbiota Transplant for the Treatment of Small Intestinal Bacterial Overgrowth Phase 1
Enrolling by invitation NCT04501380 - Efficacy of AEMCOLO (Rifamycin SV MMX) in the Treatment of Small Intestinal Bacterial Overgrowth (SIBO) Phase 2
Completed NCT03692299 - Effectiveness of Saccharomyces Boulardii for Gastrointestinal Bacterial-overgrowth in Systemic Sclerosis Phase 4
Completed NCT05915767 - Therapeutic Effect of Olive Leaf Tea on SIBO N/A
Recruiting NCT04910815 - Feasibility of a New Diagnostic Device to Assess Small Intestinal Dysbiosis in Routine Clinical Setting. N/A
Recruiting NCT04499742 - Comparative Assessment of Radioisotope Glucose and Breath Test
Enrolling by invitation NCT02458781 - Antibiotic Treatment Trial for Small Intestinal Bacterial Overgrowth Phase 4
Enrolling by invitation NCT01822470 - Small Intestinal Bacterial Overgrowth: A Prospective Registry
Terminated NCT02439307 - Effycacy of Rifaximin on Reverse Minimal Hepatic Encephalopathy and Elimation Small Intestinal Bacterial N/A
Completed NCT03216239 - SIBO & SIFO After Colectomy
Completed NCT00619970 - Is Chronic Abdominal Pain in Pediatric Patients Due to Small Intestinal Bacterial Overgrowth? N/A